Influence of blood flow and the effect of protamine on the thromboresistant properties of a covalently bonded heparin surface
- 1 October 1988
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 22 (10) , 859-868
- https://doi.org/10.1002/jbm.820221003
Abstract
Polyethylene tubings, 2‐mm inner diameter and the length of 1 m, untreated or furnished with a covalently bonded heparin surface layer, were inserted as arterio‐venous shunts bilaterally in dogs. By compressing the middle part, the initial blood flow was adjusted to 10 or 40 mL/min. The thrombogenecity of the tubings was assessed by the patency of the shunts and by assaying the generation of fibrinopeptide A (FPA) in arterial blood and in blood after its passage through the shunts. In untreated shunts clotting rapidly occurred preceded by high FPA generation in blood passing through the shunts. The blood flow in heparinized shunts remained unchanged throughout the test period. At the low flow rate a certain degree of FPA generation in the shunts occurred. At the high flow rate no changes in FPA levels occurred. The function of the heparin surface is thus flow rate dependent. Systemtic heparinization and subsequent neutralization with protamine or administration of protamine alone did not interfere with the function of the heparin surface.This publication has 20 references indexed in Scilit:
- Treatment of Acute Respiratory Failure by Extracorporeal Carbon Dioxide Elimination Performed with a Surface Heparinized Artificial LungAnesthesiology, 1987
- Thrombin inactivation on surfaces with covalently bonded heparinThrombosis Research, 1986
- Extracorporeal Elimination of Carbon Dioxide Using a Surface-Heparinized Veno-Venous Bypass SystemAnnual Northeast Bioengineering Conference, 1986
- Thrombin uptake and inhibition on endothelium and surfaces with a stable heparin coating: A comparative in vitro studyJournal of Biomedical Materials Research, 1986
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983
- Activation of Protein C In VivoJournal of Clinical Investigation, 1982
- Rapid radioimmunoassay of human fibrinopeptide A — Removal of cross-reacting fibrinogen with bentoniteThrombosis Research, 1980
- Platelet and plasma coagulation compatibility of heparinized and sulphated surfacesThrombosis Research, 1979
- Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aortaThrombosis Research, 1978
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974